Plain-English translation of NCT07175155 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
During sedated gastrointestinal endoscopy (a procedure to examine your stomach and esophagus), people with obesity often experience drops in blood oxygen levels. This trial is testing whether combining a new device called the COMBO Endoscopy Oropharyngeal Airway with high-flow oxygen therapy can prevent these dangerous drops in oxygen better than oxygen therapy alone.
More than 40% of people with obesity experience low oxygen levels during sedated stomach procedures, and current oxygen methods sometimes fail because the airway can collapse. Researchers want to see if this new combination approach can keep your oxygen levels safer throughout the procedure.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either the new COMBO breathing device combined with high-flow oxygen, or high-flow oxygen alone during your gastrointestinal endoscopy procedure. During the procedure, doctors will monitor your oxygen levels closely. The procedure itself should take no longer than 45 minutes, and your oxygen levels will be tracked throughout to see which approach works better.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
China